CDMO News
Shilpa Medicare Launches Hybrid CDMO Model for Small and Large Molecules
Shilpa Medicare has introduced a new hybrid CDMO model that caters to both small and large molecule pharmaceutical companies, including peptide-based therapeutics. The model is designed to provide flexible outsourcing solutions, with oncology as a core area of expertise. In addition
12 March 2025